USAR USA Rare Earth, Inc.

Price Chart

Executive Summary

USAR filed a DEFA14A (definitive additional proxy soliciting material) containing unaudited pro forma condensed combined financial statements for the pending acquisition of SVRE Holdings Ltd. The filing details the $3.38 billion total consideration ($300M cash + 126.85M shares of USAR common stock valued at $24.29/share), a $1.5B private placement completed in January 2026, and a $1.6B U.S. government financing package (CHIPS Act grant + senior secured debt). The pro forma combined entity shows a net loss of $75.1M for Q1 2026 and $460.1M for FY2025, with pro forma EPS of ($0.23) and ($1.65), respectively. The merger is subject to USAR stockholder approval and SEC review of the proxy statement.

Actionable Insight

Key Facts

• USAR to acquire SVRE Holdings Ltd. for total consideration of $3.38 billion: $300M cash + 126,849,307 shares of USAR common stock valued at $24.29/share (May 21, 2026 closing price)
• USAR completed a $1.5B private placement (69,767,442 shares at $21.50/share) on January 28, 2026
• USAR entered into non-binding LOIs with U.S. Department of Commerce for ~$1.6B total: $277M CHIPS Act direct funding + $1.3B senior secured debt (15-year, Treasury + 150bps); definitive agreements signed June 3, 2026
• SVRE has a $565M DFC loan facility ($325M drawn as of March 31, 2026); incremental $100M tranche must be fully disbursed before merger close
• Pro forma combined net loss: $75.1M (Q1 2026) and $460.1M (FY2025); pro forma EPS: ($0.23) and ($1.65)
• Pro forma combined total assets: $6.66B; total liabilities: $1.66B; stockholders' equity: $4.99B
• Goodwill of $1.32B recognized in preliminary purchase price allocation
• Offtake agreement for 100% of phase one production from SVRE's Pela Ema project, with U.S. government-backed counterparty; 20-year term
• Earnout shares (10.1M total) issued in April/May 2026 upon stock price milestones ($15 and $20 per share)
• Nonrecurring transaction costs of $113M estimated (investment banking, legal, audit fees)

Financial Impact

Total merger consideration of $3.38 billion; $1.5B private placement; $1.6B U.S. government financing package; pro forma combined net loss of $75.1M (Q1 2026) and $460.1M (FY2025)

Risk Factors

• Merger is subject to USAR stockholder approval and SEC review of proxy statement — no guarantee of completion
• Pro forma combined entity shows substantial net losses ($460M in FY2025) with no near-term path to profitability evident
• $1.6B U.S. government financing is contingent on achieving project, financing, and commercial milestones; non-binding LOI stage until June 3, 2026 definitive agreements
• Goodwill of $1.32B creates significant impairment risk if projected synergies or production milestones are not met
• Massive dilution: pro forma share count of 333.4M (Q1 2026) vs USAR historical 196.5M, plus additional 69.8M from private placement already issued
• Offtake agreement conditions precedent must be satisfied by June 12, 2026 long-stop date or either party may terminate without liability
• Preliminary purchase price allocation subject to material change; final accounting could differ significantly

Market Snapshot

Documents Analyzed

This report is based on 5 SEC documents filed with EDGAR.

US Market Status

Related Tickers